Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Amneal Pharmaceuticals Inc (AMRX)

4.27   0.07 (1.67%) 08-13 16:00
Open: 4.15 Pre. Close: 4.2
High: 4.305 Low: 4.101
Volume: 912,440 Market Cap: 1,280M
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in two segments, Generics and Specialty. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.31 - 4.339 4.339 - 4.364
Low: 4.031 - 4.067 4.067 - 4.099
Close: 4.214 - 4.271 4.271 - 4.323

Technical analysis

as of: 2020-08-13 4:31:32 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.75     One year: 6.38
Support: Support1: 4.05    Support2: 3.37
Resistance: Resistance1: 4.92    Resistance2: 5.46
Pivot: 4.44
Moving Average: MA(5): 4.29     MA(20): 4.48
MA(100): 4.20     MA(250): 3.90
MACD: MACD(12,26): -0.07     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 12.77     %D(3): 16.00
RSI: RSI(14): 45.05
52-week: High: 5.79  Low: 2.27  Change(%): 76.4
Average Vol(K): 3-Month: 146613  10-Days: 158209

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AMRX has closed above bottom band by 35.1%. Bollinger Bands are 6.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 13 Aug 2020
Amneal Pharmaceuticals, Inc. (AMRX) most recent report reveals some hints about its future - The News Heater

Sun, 09 Aug 2020
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Thu, 06 Aug 2020
Amneal Pharmaceuticals, Inc. (AMRX) Q2 2020 Earnings Call Transcript - Motley Fool

Thu, 06 Aug 2020
Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

Mon, 03 Aug 2020
Amneal (AMRX) to Report Q2 Earnings: What's in the Cards? - Yahoo Finance

Thu, 30 Jul 2020
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers Specialty & Generic
Shares Out. (M) 147
Shares Float (M) 94
% Held by Insiders 10.36
% Held by Institutions 69.44
Shares Short (K) 7,390
Shares Short P. Month (K) 6,090

Stock Financials

EPS -1.455
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.160
Profit Margin -11.85
Operating Margin 5.64
Return on Assets (ttm) 1.4
Return on Equity (ttm) -58.8
Qtrly Rev. Growth 11.7
Gross Profit (p.s.) 3.373
Sales Per Share 11.405
EBITDA (p.s.) 2.112
Qtrly Earnings Growth
Operating Cash Flow (M) 159
Levered Free Cash Flow (M) 6

Stock Valuations

PE Ratio -2.93
PEG Ratio
Price to Book value 1.98
Price to Sales 0.37
Price to Cash Flow 3.95

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.